SUB TENON'S ANECORTAVE ACETATE FOR GLAUCOMA


OSN SuperSite - Preliminary analysis suggests anecortave acetate could
sustained IOP control

According to this review:


Open-angle glaucoma patients treated with a single sub-Tenon injection of anecortave acetate showed a significant, sustained reduction in IOP (average 7.2mmHg) over 3 months, according to an interim analysis of data from a clinical study.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH